The Medical Scientist Training (MST) Program at the University of Virginia prepares students for future careers in academic medicine. The goal of our Program is to provide students with the knowledge and skills to lead efforts to identify disease mechanisms, and to treat and cure human disease in the 21st Century. We have developed a highly integrated curriculum, as well as numerous MST policies and programmatic activities (e.g. a monthly research in progress dinner, a Molecular Medicine Seminar series, clinical internships with physician scientists, etc.) to optimize the development of trainees as physician scientists. From the onset, students take a combination of medical, graduate, and unique MST Program courses. These courses, combined with the elective fourth year of the medical curriculum allows students to complete requirements for the M.D. and Ph.D. degrees in an average of 7 years. The summer months during the first two years are devoted to completing research rotations. Beginning in year 03, students enter Graduate School in one of six degree-granting basic science departments, two degree-granting interdisciplinary programs, or an affiliated science/engineering department in the college. After completing their Ph.D., students return to Medical School and complete 13 months of required clinical clerkships, as well as elective clerkships as desired. We have an active recruiting program that consists of a Summer Undergraduate Research Program (SRIP), faculty visits to undergraduate campuses, and an early admissions program in the fall, in addition to standard admissions in the spring. We have over 150 primary mentors with whom students can conduct their thesis projects in an area of major biomedical significance. All have national level peer review funding and are recognized as leaders in their respective disciplines. We also have many clinician scientist co-mentors who serve to enhance the biomedical relevance/significance of dissertation projects. The program has a track record of its past graduates having highly successful careers as physician scientists at universities, the NIH, and the FDA, and many currently have their own independently funded laboratories. In summary, we feel that the unique training program that we have put in place, combined with our exceptional strengths in the basic and clinical sciences, provide an extremely strong environment for training physician scientists who will become leading academic investigators in this century. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007267-27
Application #
6894379
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
1977-07-01
Project End
2010-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
27
Fiscal Year
2005
Total Cost
$425,779
Indirect Cost
Name
University of Virginia
Department
Physiology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Adamson, Samantha E; Polanowska-Grabowska, Renata; Marqueen, Kathryn et al. (2018) Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report. Arterioscler Thromb Vasc Biol 38:1020-1029
Rowley, Carol A; Anderson, Christopher J; Kendall, Melissa M (2018) Ethanolamine Influences Human Commensal Escherichia coli Growth, Gene Expression, and Competition with Enterohemorrhagic E. coli O157:H7. MBio 9:
Suzich, Jon B; Cliffe, Anna R (2018) Strength in diversity: Understanding the pathways to herpes simplex virus reactivation. Virology 522:81-91
Gilchrist, Carol A; Cotton, James A; Burkey, Cecelia et al. (2018) Genetic Diversity of Cryptosporidium hominis in a Bangladeshi Community as Revealed by Whole-Genome Sequencing. J Infect Dis 218:259-264
Zhang, Y; Kim, J; Mueller, A C et al. (2018) Correction to: Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma. Cell Death Differ :
Harbom, Lise J; Rudisill, Taylor L; Michel, Nadine et al. (2018) The effect of rho kinase inhibition on morphological and electrophysiological maturity in iPSC-derived neurons. Cell Tissue Res :
Little, Jessica Neville; Dwyer, Noelle D (2018) p53 deletion rescues lethal microcephaly in a mouse model with neural stem cell abscission defects. Hum Mol Genet :
Lammert, Catherine R; Frost, Elizabeth L; Bolte, Ashley C et al. (2018) Cutting Edge: Critical Roles for Microbiota-Mediated Regulation of the Immune System in a Prenatal Immune Activation Model of Autism. J Immunol 201:845-850
Carlton, Anne L; Illendula, Anuradha; Gao, Yan et al. (2018) Small molecule inhibition of the CBF?/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition. Gynecol Oncol 149:350-360
Stevens, Jacqueline S; Criss, Alison K (2018) Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae. Curr Opin Hematol 25:13-21

Showing the most recent 10 out of 322 publications